您的位置: 首页 > 农业专利 > 详情页

METHODE ET COMPOSITION DESTINEES A INHIBER LA PROLIFERATION DE CELLULES CANCEREUSES A L'AIDE DE L'UREASE ET DE COMPOSES ANTI-CANCEREUX FAIBLEMENT BASIQUES
专利权人:
HELIX BIOPHARMA CORP.
发明人:
SEGAL, DONALD,MCELROY, JERRY,CHAO, HEMAN,WONG, WAH Y.,DOCHERTY, JOHN,DICKSTEIN, JODI
申请号:
CA2493282
公开号:
CA2493282C
申请日:
2005.01.31
申请国别(地区):
CA
年份:
2020
代理人:
摘要:
Improvements in methods of treating cancer with weakly basic anti-cancer compounds are provided. In one aspect, the invention provides an improvement in a method of treating cancer cells whose extracellular environment contains 1-8 mM urea, by exposing the cells to a weakly basic anti-cancer compound which is effective in inhibiting the growth of the cells. The improvement includes (a) exposing the cells to a urease enzyme composition and, (b) by step (a), reducing the amount of anti- cancer compound required to produce a given extent of inhibition in the growth of the cells when the cells are exposed to the anti-cancer agent. Methods of potentiating the specific therapeutic activity of a weakly basic anti-cancer compound in the treatment of a given mammalian cancer which is responsive to the compound are provided as are pharmaceutical compositions for use in intravenous administration to a subject are also provided.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充